Our vision is to be the world’s first choice for dynamic and progressive prosthetic, orthotic and assistive technology products and services
Paul Steeper added, “We have enjoyed our time with Dunedin and greatly appreciate the support we have received. We are now looking forward to the future as we seek to further strengthen our existing positive relationships with customers, our distributors and our suppliers, and continuing to provide the best products and services to the industry”.
Nicholas Hoare from Dunedin said of the investment, “We invested in Steeper in 2005 to support its growth plans helping it to break into new markets including the US and launching new products such as the bebionic hand. The sale to Ottobock is an excellent fit and we are confident that the business will continue to deliver on its growth ambitions.”
KPMG (Christian Mayo and Ben Taylor) advised the shareholders of Steeper on the deal. Christian Mayo, partner and head of corporate finance at KPMG in Yorkshire, said: “When it comes to the wider industry, MedTech is an exciting, high-growth sector that is continually evolving – particularly in our region. As a result, we’re seeing a great deal of interest from both the investment community and trade buyers for this type of business and it’s an area we expect to see more activity in throughout the year ahead.”
For further information on Steeper Group, please contact email@example.com.